Rocket Pharmaceuticals, Inc. Common Stock
$3.37
-$0.13 (-3.71%)
$3.35Day Range$3.56
Key Statistics
Market Cap
$369.94M
Shares Outstanding
109.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 18, 2015
Round Lot
100
Locale
US
Trading Data
Day Open
$3.47
Day High
$3.56
Day Low
$3.35
Volume
1.60M
VWAP
$3.41
Prev Close
$3.50
Transactions
--
Acc. Volume
--
About Rocket Pharmaceuticals, Inc. Common Stock
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
PHARMACEUTICAL PREPARATIONSSIC 2834202 employees350 FIFTH AVENUE, NEW YORK, NY, 10118646-440-9100IPO Feb 18, 2015US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001281895
- Composite FIGI
- BBG000WG3567
- Share Class FIGI
- BBG001T92156
- Ticker Root
- RCKT
- SIC Code
- 2834
About Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Stock
Rocket Pharmaceuticals, Inc. Common Stock (RCKT) closed the 2026-09-18 session at $3.37, down 3.71% versus the previous close (-0.13). The stock opened at $3.47 and traded between $3.35 and $3.56 during that session. Session trading volume was 1.6M shares. The volume-weighted average price (VWAP) is $3.41.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Rocket Pharmaceuticals, Inc. Common Stock has a market capitalization of $369.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. RCKT is listed on the XNAS exchange. The company employs approximately 202 people. Rocket Pharmaceuticals, Inc. Common Stock is headquartered in NEW YORK, NY. The recorded listing date is 2015-02-18.
On this page you can find market RCKT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.